Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Other Working Capital Changes (2023 - 2025)

Onconetix (ONCO) has disclosed Other Working Capital Changes for 2 consecutive years, with -$1.0 million as the latest value for Q4 2024.

  • On a quarterly basis, Other Working Capital Changes fell 354.51% to -$1.0 million in Q4 2024 year-over-year; TTM through Dec 2024 was -$1.0 million, a 346.75% decrease, with the full-year FY2024 number at -$1.0 million, down 346.75% from a year prior.
  • Other Working Capital Changes was -$1.0 million for Q4 2024 at Onconetix, down from -$411781.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $419530.0 in Q1 2024 to a low of -$1.0 million in Q4 2024.